Previous 10 | Next 10 |
BOSTON, July 28, 2020 (GLOBE NEWSWIRE) -- resTORbio resTORbio, Inc. (Nasdaq: TORC) today announced the award from the National Institute on Aging to fund a randomized, double-blind, placebo-controlled pilot study of RTB101, an investigational orally-administered potent small molecule inhibi...
These Penny Stocks Saw Big Volume At The End of The Week With great power comes great responsibility. If you know how to trade penny stocks right now, you definitely have some power. This takes into consideration the herds of new traders making their way into the stock market today. Why does...
NEW YORK , July 13, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City , is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimat...
LM Funding America (NASDAQ: LMFA ) +83% . More news on: LM Funding America, Inc., Myomo, Inc., Electrameccanica Vehicles Corp., Stocks on the move, , Read more ...
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - IFF, GRUB, TORC NEW YORK, NY / ACCESSWIRE / June 24, 2020 / Halper Sadeh LLP, a global investor rights law f...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WLTW, GRUB, TORC NEW YORK, NY / ACCESSWIRE / June 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, c...
Are These On Your List Of Penny Stocks To Watch Before June 2020? The stock market today is jumping again and so are a number of penny stocks . One thing brought to my attention was the misconception that penny stocks are meant for short-term day trades. Now, before I get to my point, let me ...
ARCA biopharma (NASDAQ: ABIO ) +59% on launching AB201 program in COVID-19. More news on: ARCA biopharma, Inc., PhaseBio Pharmaceuticals, Inc., Technical Communications Corporation, Stocks on the move, , Read more ...
ResTORbio (NASDAQ: TORC ) initiates a randomized placebo-controlled study evaluating RTB101 for the prevention of COVID-19 infection in nursing home residents. More news on: resTORbio, Inc., Healthcare stocks news, Stocks on the move, Read more ...
BOSTON, May 28, 2020 (GLOBE NEWSWIRE) -- resTORbio (Nasdaq: TORC) today announced the initiation of a randomized, double-blind, placebo-controlled trial of RTB101, an investigational orally-administered potent small molecule inhibitor of target of rapamycin complex 1 (TORC1), as compared to...
News, Short Squeeze, Breakout and More Instantly...
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -...
MENLO PARK, Calif. , Aug. 5, 2020 /PRNewswire/ -- Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the t...
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today provided a corporate update and reported financial results ...